4 terminated. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Terminated 4 |
Follow Urinary Retention: new trials by email Literature Review of Urinary Retention trials Research Report on Urinary Retention
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Tamsulosin on Postoperative Urinary Retention Tamsulosin, Placebo - Urinary Retention | Phase 4 | Terminated | Wake Forest University Health Sciences | 4 | 2021-10-19 | 2024-01-31 |
| Post-Operative Urinary Retention (POUR) in Thoracic Surgery Patients Receiving Prophylactic Tamsulosin Tamsulosin Hydrochloride - Thoracic Diseases, Urinary Retention | Phase 4 | Terminated | University of Massachusetts, Worcester | 109 | 2021-08-01 | 2024-11-07 |
| Study to Prevent Postoperative Urinary Retention TAMSULOSIN Mepha Ret Depocaps 0.4 mg, Control Intervention - Urinary Retention, Inguinal Hernia | Phase 4 | Terminated | Antonio Nocito, MD | 312 | 2020-11-01 | 2026-02-17 |
| An Open Label Study to Evaluate the Effects of Ezogabine/Retigabine Added to Existing Anti-epileptic Drug(s) on Urinary Voiding Function in Subjects With Partial Onset Seizures ezogabine/retigabine - Epilepsy | Phase 4 | Terminated | GlaxoSmithKline | 10 | 2013-03-27 | 2020-12-04 |
Epilepsy (1) · Hernia, Inguinal (1) · Thoracic Diseases (1) · Urinary Tract Infections (1)
Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Male Urogenital Diseases (4) · Urination Disorders (4) · Urogenital Diseases (4) · Urologic Diseases (4) · Brain Diseases (1) · Central Nervous System Diseases (1) · Hernia (1) · Hernia, Abdominal (1) · Infections (1) · Nervous System Diseases (1) · Pathological Conditions, Anatomical (1) · Pathological Conditions, Signs and Symptoms (1) · Respiratory Tract Diseases (1)
Tamsulosin (2) · calcium D-pantothenate, L-cysteine drug combination (1) · ezogabine (1)
Antonio Nocito, MD (1) · GlaxoSmithKline (1) · University of Massachusetts, Worcester (1) · Wake Forest University Health Sciences (1)
United States (3) · France (1) · Poland (1) · Switzerland (1)
Antonio Nocito, Prof (1) · Feiran Lou, MD (1) · Majid Mirzazadeh, MD (1)